Annual D&A
$13.04 M
+$4.60 M+54.55%
December 31, 2023
Summary
- As of February 8, 2025, IPSC annual depreciation & amortization is $13.04 million, with the most recent change of +$4.60 million (+54.55%) on December 31, 2023.
- During the last 3 years, IPSC annual D&A has risen by +$11.64 million (+830.39%).
- IPSC annual D&A is now at all-time high.
Performance
IPSC Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$3.30 M
-$164.00 K-4.74%
September 30, 2024
Summary
- As of February 8, 2025, IPSC quarterly depreciation & amortization is $3.30 million, with the most recent change of -$164.00 thousand (-4.74%) on September 30, 2024.
- Over the past year, IPSC quarterly D&A has dropped by -$52.00 thousand (-1.55%).
- IPSC quarterly D&A is now -7.15% below its all-time high of $3.55 million, reached on December 31, 2023.
Performance
IPSC Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$13.54 M
-$52.00 K-0.38%
September 30, 2024
Summary
- As of February 8, 2025, IPSC TTM depreciation & amortization is $13.54 million, with the most recent change of -$52.00 thousand (-0.38%) on September 30, 2024.
- Over the past year, IPSC TTM D&A has increased by +$1.21 million (+9.80%).
- IPSC TTM D&A is now -0.38% below its all-time high of $13.59 million, reached on June 30, 2024.
Performance
IPSC TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
IPSC Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +54.5% | -1.6% | +9.8% |
| 3 y3 years | +830.4% | +2.0% | +15.2% |
| 5 y5 years | +5138.6% | +2.0% | +15.2% |
IPSC Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +248.0% | -7.2% | +213.8% | -0.4% | +261.2% |
| 5 y | 5-year | at high | +5138.6% | -7.2% | +1549.0% | -0.4% | +6669.0% |
| alltime | all time | at high | +5138.6% | -7.2% | +1549.0% | -0.4% | +6669.0% |
Century Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.30 M(-4.7%) | $13.54 M(-0.4%) |
| Jun 2024 | - | $3.46 M(+7.3%) | $13.59 M(+1.7%) |
| Mar 2024 | - | $3.23 M(-9.2%) | $13.36 M(+2.4%) |
| Dec 2023 | $13.04 M(+54.5%) | $3.55 M(+6.0%) | $13.04 M(+5.8%) |
| Sep 2023 | - | $3.35 M(+3.6%) | $12.33 M(+4.9%) |
| Jun 2023 | - | $3.23 M(+11.2%) | $11.75 M(+15.4%) |
| Mar 2023 | - | $2.91 M(+2.5%) | $10.19 M(+20.7%) |
| Dec 2022 | $8.44 M | $2.84 M(+2.3%) | $8.44 M(+26.9%) |
| Sep 2022 | - | $2.77 M(+66.3%) | $6.65 M(+35.1%) |
| Jun 2022 | - | $1.67 M(+43.8%) | $4.92 M(+17.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $1.16 M(+10.4%) | $4.19 M(+11.8%) |
| Dec 2021 | $3.75 M(+167.3%) | $1.05 M(+0.7%) | $3.75 M(+16.9%) |
| Sep 2021 | - | $1.04 M(+11.7%) | $3.21 M(+24.6%) |
| Jun 2021 | - | $935.00 K(+30.2%) | $2.57 M(+34.0%) |
| Mar 2021 | - | $718.00 K(+40.8%) | $1.92 M(+36.9%) |
| Dec 2020 | $1.40 M(+463.1%) | $510.00 K(+24.4%) | $1.40 M(+57.2%) |
| Sep 2020 | - | $410.00 K(+45.4%) | $892.00 K(+85.1%) |
| Jun 2020 | - | $282.00 K(+41.0%) | $482.00 K(+141.0%) |
| Mar 2020 | - | $200.00 K | $200.00 K |
| Dec 2019 | $249.00 K | - | - |
FAQ
- What is Century Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Century Therapeutics?
- What is Century Therapeutics annual D&A year-on-year change?
- What is Century Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Century Therapeutics?
- What is Century Therapeutics quarterly D&A year-on-year change?
- What is Century Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Century Therapeutics?
- What is Century Therapeutics TTM D&A year-on-year change?
What is Century Therapeutics annual depreciation & amortization?
The current annual D&A of IPSC is $13.04 M
What is the all time high annual D&A for Century Therapeutics?
Century Therapeutics all-time high annual depreciation & amortization is $13.04 M
What is Century Therapeutics annual D&A year-on-year change?
Over the past year, IPSC annual depreciation & amortization has changed by +$4.60 M (+54.55%)
What is Century Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of IPSC is $3.30 M
What is the all time high quarterly D&A for Century Therapeutics?
Century Therapeutics all-time high quarterly depreciation & amortization is $3.55 M
What is Century Therapeutics quarterly D&A year-on-year change?
Over the past year, IPSC quarterly depreciation & amortization has changed by -$52.00 K (-1.55%)
What is Century Therapeutics TTM depreciation & amortization?
The current TTM D&A of IPSC is $13.54 M
What is the all time high TTM D&A for Century Therapeutics?
Century Therapeutics all-time high TTM depreciation & amortization is $13.59 M
What is Century Therapeutics TTM D&A year-on-year change?
Over the past year, IPSC TTM depreciation & amortization has changed by +$1.21 M (+9.80%)